Comparison Overview

Starkstrom

VS

Edwards Lifesciences

Starkstrom

33 Turn Street, Syston, England, LE7 1HP, GB
Last Update: 2025-05-04 (UTC)
Between 750 and 799

Starkstrom’s mission is to provide clinical infrastructure solutions to hospitals for their critical areas by offering high quality products and services for better patient outcomes, process and cost-efficiencies. Starkstrom Limited, a Progility PLC company, is an innovative healthcare equipment and service company founded in 1971, which initially specialised in the design and manufacture of control panel equipment. INNOVATION - Since installing the first isolated power solution in Chelsea and Westminster Hospital in 1995, to meet the new IEC directive that came into force, Starkstrom has developed a range of associated products including the touch screen Theatre Control Panel, Starkstrom’s Automatic Transfer Switch (SATS), Earthing accessories and a wide range of Clinical Pendants which have recently been enhanced with additional safety features of cable management and ambient lighting. PORTFOLIO ENHANCEMENT – Starkstrom also have exclusive UK distribution of KLS Martin’s Operating Lights (the E-series and award winning marLED® V-series range) and high frequency electrosurgical units (maxium®). Similarly, Starkstrom also promote Merivaara’s range of Operating Tables which include Promerix and Practico. SERVICE ORIENTATED - With its manufacturing site in the UK, Starkstrom has the ability and flexibility to provide bespoke solutions to meet customers’ needs. This is supported by a strong service and maintenance team, with 20 personnel in the field, to support products once they have been installed. CONTINUOUS IMPROVEMENT - Starkstrom is continually striving to improve the quality of its product and service offering moving towards medical devices that are: (1) easier to use without compromising safety, (2) more competitively priced without compromising quality, (3) supported with quality training and bespoke service and maintenance packages.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 80
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Edwards Lifesciences

One Edwards Way, None, Irvine, CA, US, 92614
Last Update: 2025-08-20 (UTC)
Between 800 and 849

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more.  Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 13,399
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/starkstrom.jpeg
Starkstrom
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Starkstrom
100%
Compliance Rate
0/4 Standards Verified
Edwards Lifesciences
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Starkstrom in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Edwards Lifesciences in 2025.

Incident History — Starkstrom (X = Date, Y = Severity)

Starkstrom cyber incidents detection timeline including parent company and subsidiaries

Incident History — Edwards Lifesciences (X = Date, Y = Severity)

Edwards Lifesciences cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/starkstrom.jpeg
Starkstrom
Incidents

No Incident

https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
Incidents

No Incident

FAQ

Edwards Lifesciences company demonstrates a stronger AI Cybersecurity Score compared to Starkstrom company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Edwards Lifesciences company has disclosed a higher number of cyber incidents compared to Starkstrom company.

In the current year, Edwards Lifesciences company and Starkstrom company have not reported any cyber incidents.

Neither Edwards Lifesciences company nor Starkstrom company has reported experiencing a ransomware attack publicly.

Neither Edwards Lifesciences company nor Starkstrom company has reported experiencing a data breach publicly.

Neither Edwards Lifesciences company nor Starkstrom company has reported experiencing targeted cyberattacks publicly.

Neither Starkstrom company nor Edwards Lifesciences company has reported experiencing or disclosing vulnerabilities publicly.

Neither Starkstrom nor Edwards Lifesciences holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Starkstrom company nor Edwards Lifesciences company has publicly disclosed detailed information about the number of their subsidiaries.

Edwards Lifesciences company employs more people globally than Starkstrom company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Starkstrom nor Edwards Lifesciences holds SOC 2 Type 1 certification.

Neither Starkstrom nor Edwards Lifesciences holds SOC 2 Type 2 certification.

Neither Starkstrom nor Edwards Lifesciences holds ISO 27001 certification.

Neither Starkstrom nor Edwards Lifesciences holds PCI DSS certification.

Neither Starkstrom nor Edwards Lifesciences holds HIPAA certification.

Neither Starkstrom nor Edwards Lifesciences holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X